EUVIMEDEUVIMED entdecken
Crossref

The correlation between IGF-1R and HER-2 expression with mitosis count and histopathological grade in invasive breast carcinoma of no special type

Yessy Setiawati, Aswiyanti Asri, Rosfita Rasyid

Majalah Patologi Indonesia · 2020

DOI: 10.55816/mpi.v29i3.442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Majalah Patologi Indonesia, 2020. Verfasst von Yessy Setiawati und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BackgroundThe IGF-1R signaling pathways have cross-talk with HER-2 signaling pathways and was thought to be one of the resistance mechanism intrastuzumab therapy. This research was proposed to analyze the correlation between IGF-1R and HER-2 expression with mitosis count andhistopathological grade in invasive breast carcinoma of no special type.MethodsThis research was a cross-sectional design. A total of fifty-five invasive breast carcinoma of no special type cases diagnosed in theAnatomical Pathology Centre Diagnostic of Medical Faculty of Andalas University in a period of 2014-2015 were collected and stainedimmunohistochemically with IGF-1R and HER-2 antibodies. IGF-1R and HER-2 expression were examined and their correlation with mitosiscount and histopathological grade were statistically analyzed with T-test, Oneway Anova and Chi-Square test.ResultsIGF-1R cytoplasm and membranous expression were found positive in 18.2% and 34.5% cases respectively, meanwhile, HER-2 expressionswere found positive in 23.6% cases of invasive breast carcinoma of no special type. There were significant correlations between IGF-1Rcytoplasm expression with mitosis count (p=0.049). There were no significant correlations between IGF-1R membranous expression withmitosis count (p=0.641) with histopathological grade (p=1.00). There were no significant correlations between HER-2 expression withmitosis count (p=0,495) and histopathological grade (p=1.000).ConclusionIGF-1R expressions have a significant correlation with mitosis count rather than HER-2 expressions. Inhibition it’s signaling pathways mayhave therapeutic value in breast carcinoma. Combination therapy of anti-HER-2 and anti-IGF-1R are expected to overcome resistance withtrastuzumab in HER-2 positive breast carcinoma

Zitieren

APA

Setiawati, Y., Asri, A., & Rasyid, R. (2020). The correlation between IGF-1R and HER-2 expression with mitosis count and histopathological grade in invasive breast carcinoma of no special type. Majalah Patologi Indonesia. https://doi.org/10.55816/mpi.v29i3.442

Vancouver

Setiawati Y, Asri A, Rasyid R. The correlation between IGF-1R and HER-2 expression with mitosis count and histopathological grade in invasive breast carcinoma of no special type. Majalah Patologi Indonesia. 2020. doi:10.55816/mpi.v29i3.442

BibTeX
@article{Setiawati2020,
  author = {Setiawati, Yessy and Asri, Aswiyanti and Rasyid, Rosfita},
  title = {The correlation between IGF-1R and HER-2 expression with mitosis count and histopathological grade in invasive breast carcinoma of no special type},
  journal = {Majalah Patologi Indonesia},
  year = {2020},
  doi = {10.55816/mpi.v29i3.442}
}
Kostenlos starten →